Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Motif Bio Plc LSE:MTFB London Ordinary Share GB00BVVT4H71 ORD 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 0.50 0.40 0.55 - 0.00 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 3.2 -1.5 - 3

Motif Bio Share Discussion Threads

Showing 8776 to 8800 of 9100 messages
Chat Pages: Latest  352  351  350  349  348  347  346  345  344  343  342  341  Older
DateSubjectAuthorDiscuss
22/12/2020
18:54
Laughable how they feel we have fallen for their ruse about 40 companies and several at term sheet stage but the “search goes on for a suitable RTO” ok if the term sheets were needing to be negotiated it would shave been done a month ago so clearly they had fallen away otherwise why say the search goes on. Just trying to ale themselves look adequate at best but failing miserably
scottdavid70
22/12/2020
14:06
To be fair the no clinical trails comment on the WebCast of the 19th February 2019 that ended up being another full phase 3 trail costing $40 Million and 3.5 years is how did that part it...disingenuous at best:-)
scottdavid70
22/12/2020
13:40
The main thrust of the story for them is the strict cost controls supposedly Motif was under in 2019 and the almost US $1.1 MILLION two Director’s took home along with a few pensionable benefits and are THEN IN LINE FOR A BONUS AND A HUGE AMOUNT IN DEFERRED PAYMENTS. This draining affect in terms of dilution through unnecessary fund raises has brought the Board of Directors culpable for these vast sums to be paid out sharply into focus along with the affiliated companies involved such as Walbrook and Peel Hunt. Reputation damage here is simply immense. That is simply unpalatable to them in these horrendous times for ordinary investors caught up in the Machiavellian spin that has unfolded here
scottdavid70
22/12/2020
13:20
Holding people accountable is extremely en bouvier at these difficult times. Certainly this story is resonating with a lot of different media outlets
scottdavid70
22/12/2020
12:22
Walbrook Northland Capital Peel Hunt X 100 Zacks Motif Bio all Board Members past and current SP Angel
scottdavid70
22/12/2020
12:21
Utterly disgusting and shambolic way to treat shareholders who have funded their lavish lifestyles. Going stealth isn’t going to make people forget what has unfolded here. Regardless what unfold here ultimately there has to be a review, something I appreciate they don’t like to do judging by their 2019 lack of as per Corporate Governance, by others to see if these Directors are fit to continue as such in the future.
scottdavid70
22/12/2020
11:27
Wake up wake up MTFB board of directors
jimbob999
22/12/2020
09:24
So a new variant of Covid - vaccine may not work - therefore therapeutics very important AMR Fund needing new antibiotics to get 3-4 new antibiotics to market in 10 years - we have one that needs 3.5 years and a mere $40 million - they have a billion dollars to spend Supposedly 30 companies wanted to do a RTO and several have got to Term Sheet stage So the question is why hasn’t a deal been done as we have less than 30 business days till the company delists All bases covered still Graham?
scottdavid70
21/12/2020
20:31
I see Walbrook are pumping Great Western Mining via their usual media outlet Proactive. Gold and silver coming in December if you believe it... Wait till the Motif story gets told soon. No one will touch anything promoted via those channels Gold is promised here too $325,000 in deferred payments...
scottdavid70
21/12/2020
17:55
Several competitors at Term Sheet stage is enough to keep them competitive to do the best deal. No need to keep searching for a MORE suitable one when you have had a choice of 30 FFS. Amongst them there was definitely one better than we currently had. Sadly the wrong people are at the helm and that’s because there was no Board review in 2019 against everything Corporate Governance stands for
scottdavid70
21/12/2020
17:52
I agree Chuffer - looking back now at the 12th October Interims where it says several companies have reached the term sheet stage BUT the SEARCH is still on for a suitable RTO they were trying to obfuscate the fact those term sheets were no longer in play. Rinse and repeat methodologically from these quite special breed of Directors sadly More for the book
scottdavid70
21/12/2020
15:18
Not that is was ever on!
chuffer2
21/12/2020
15:05
Term Sheet to deal - 4-5 weeks in general Would appear it’s all off as we haven’t heard from the company No other reason for the complete silence as far as my experience tells me
scottdavid70
21/12/2020
14:36
No point as they are just another leech sucking money from the pot. Have yet to see a pr/ir company that looks after shareholders they simply get paid a lot of money as a front for corrupt bod members.
chuffer2
21/12/2020
14:34
I will say it again 2018 was the year of ‘strict cost controls’ and two directors here trousered almost US $1.1 million in salary. 1) That doesn’t sound like strict cost control to anyone I speak too 2) with that money neither bought shares in the company. Would have showed a bit of confidence and solidarity with shareholders but no that would have been wasting cash like they have asked shareholders to do given the predictions they have made to pay them so handsomely 3) They still want a Bonus - Lumsden a straight up one and Gold a deferred one. $100,000 and $325,000 respectively if they close a RTO
scottdavid70
21/12/2020
14:29
Several interested parties in June - Peel Hunt whom have surveyed the skeletons here for a millionth time needed to advise a Board that hadn’t done a review of its make up or performance in 2019 as per Corporate Governance - thereby eating up valuable cash that they could have saved if they had done Corporate Governance and got people on the Board whom understand RTO’s - Term Sheets 12th October written in such a way as to read it both ways possible still active or not given they are still searching for a suitable RTO in the next sentence- 70 days later the sound of crickets from all involved here. What could have gone wrong given everything has gone so right before now....
scottdavid70
21/12/2020
14:24
Chuffer - you called up Walbrook recently and asked them? You seem to have a better relationship with them than me for some unknown reason...
scottdavid70
21/12/2020
10:39
So why is there a possibility in the Interims of shareholders being significantly diluted again given we were told that the company was fully funded? When’s enough Graham and Jon?
scottdavid70
21/12/2020
10:38
They were fully funded supposedly in May 2018 and raised $10 million for regulatory and pre-authorisation supposedly. What they ended up doing was dropping the EMA submission and HABP trials. So what happens to the money earmarked for those two significant events? We know the millions raised have been trousered by two of the Directors under ‘strict cost controls’
scottdavid70
21/12/2020
10:36
One thing this company is very good at is giving no updates - No update on the Lamellar tie from May last year No update on US Army trials from October last year No update on Iclaprim situation No update on Term Sheet negotiations What they are good at is slipping in things like no Board Reviews which goes against good Corporate Governance and significant dilution potential in Annual and Interim Reports even when they have stated they are fully funded
scottdavid70
21/12/2020
07:55
So the deals that were on offer to get Peel Hunt involved looked good enough for Motif to pay them yet here we are 7 Months later with no deal? Money for old rope
scottdavid70
21/12/2020
07:25
Fair to say I think this is ‘attempt’; at a RTO with ‘several’; companies who want to get their Covid therapeutics is beginning to feel like a huge con. After over 70 days since several term sheets were agreed and we are in a huge tsunami of Covid cases worldwide and vaccines causing adverse reactions they can’t close a deal suggests there wasn’t one to begin with. Happy to be proved wrong but can’t see a deal being done now in the timeframe they have left
scottdavid70
20/12/2020
15:29
18 December 2018 Clinical stage bio company Motif Bio could see its share price surge early next year, argued Peel Hunt, with the US FDA due to give possible approval to Motif's antibiotic iclaprim on 13 February. Trading at 26p, Peel Hunt is targeting 95p. There they were again - Peel Hunt Wrong then and more than likely wrong choice for the company now but they know the skeletons so an easy choice maybe?
scottdavid70
20/12/2020
15:20
Why did Motif Boo raise $10 million in May 2018 when they had said they were fully funded to FDA decision? Why with this extra cash that they supposedly didn’t originally need did Motif then also pull EMA submission and HARP trials? Second chapter will explain in the book
scottdavid70
20/12/2020
13:04
Pfizer vaccine paused in multiple US states as there are many allergic reactions. One Chicago hospital has stopped the program as 4 workers have suffered reactions If there is genuinely a company wanting a Covid therapeutic to come to market there has been without a shadow of a doubt no better time to show it and do a deal with Motif. Let’s see next week. Hopes are low obviously as we haven’t had a review of the Board last year to determine if the BOD members were of the best skill set shareholders needed for the restructured company That’s why have you have Corporate Governance
scottdavid70
Chat Pages: Latest  352  351  350  349  348  347  346  345  344  343  342  341  Older
ADVFN Advertorial
Your Recent History
LSE
MTFB
Motif Bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210226 07:54:10